YWYu Wen

Yu Wen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Wen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Guoqing Ouyang

    Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China

    2 shared publications
  • He Huang

    Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, 410078, PR China

    2 shared publications
  • Li Xiong

    Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China

    2 shared publications
  • Liangwu Lin

    State Key Laboratory for Powder Metallurgy, Central South University, Changsha Hunan, 410083, PR China

    2 shared publications
  • Xiongying Miao

    Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China

    2 shared publications
  • Zhipeng Liu

    Department of General Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, PR China

    2 shared publications

Latest Publications

  • Open Access

    Investigation of Copper Cysteamine Nanoparticles as a New Type of Radiosensitiers for Colorectal Carcinoma Treatment

    by Zhipeng Liu, Li Xiong, Guoqing Ouyang, Lun Ma, Sunil Sahi, Kunpeng Wang, Liangwu Lin, He Huang, Xiongying Miao, Wei Chen, et al.

    Copper Cysteamine (Cu-Cy) is a new photosensitizer and a novel radiosensitizer that can be activated by light, X-ray and microwave to produce singlet oxygen for cancer treatment. However, the killing mechanism of Cu-Cy nanoparticles on cancer cells is not clear yet and Cu-Cy nanoparticles as novel radiosensitizers have never been tested on colorectal cancers. Here, for the first time, we investigate the treatment efficiency of Cu-Cy nanoparticles on SW620 colorectal cells and elucidate the underlying mechanisms of the effects. The results show that X-ray activated Cu-Cy nanoparticles may kill SW620 cancerscells is in a dose-dependent manner. The JC-1 staining shows the mitochondrial membrane potential is decreased after the treatment. The observations confirm that Cu–Cy nanoparticles may improve X-ray radiotherapy on cancer treatment and X-ray activated Cu-Cy nanoparticles can be efficiently destroy colorectal cancer cells by inducing apoptosis as well as autophagy. As a new type of radiosensitizers and photosensitizers, Cu-Cy nanoparticles have a good potential for colorectal cancer treatment and the discovery of autophagy induced by X-ray irradiated Cu-Cy nanoparticles sheds a good insight to the mechanism of Cu-Cy for cancer treatment as a new radiosensitizers.


  • Open Access

    Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells

    by Li Xiong, Zhipeng Liu, Guoqing Ouyang, Liangwu Lin, He Huang, Hongxiang Kang, Wei Chen, Xiongying Miao, Yu Wen

    Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells